CHRS Competitors & Alternatives
Compare Coherus BioSciences Inc with similar stocks in the same industry
Biotechnology
CHRS
Main Stock$1.45
Tradestie Score
58
Market Cap
$188.29M
Revenue Growth
0.6%
Analyst Upside
+437.9%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DBVT
DBV Technologies S.A.
|
$15.82
|
$275.54M | - | 55 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.08
|
$275.13M | - | 55 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$20.59
|
$269.08M | - | 57 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.89
|
$258.18M | - | 59 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$35.34
|
$256.54M | - | 64 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$14.98
|
$211.22M | - | 54 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.56
|
$202.58M | - | 56 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$27.74
|
$188.81M | 333.6 | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.84
|
$170.45M | - | 55 | Compare |
More CHRS Analysis
Data updated: Jul 06, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry